History
# Registration date Revision Id
2 2018-07-22, 1397/04/31 54402
1 2016-10-29, 1395/08/08 10632
Changes made to previous revision
  • Help:

    Red color represents old content. It may be empty showing addition in the new version.
    Green color represents new content. It may be empty showing deletion in the new version.

    Inline Side by side
    Added new contents, deleted old contents, contents that are not changed.
    New table contents New table contents
    Old table contents Old table contents
    Unchanged contents Unchanged contents
    Added new contents, contents that are not changed.
    Deleted old contents, contents that are not changed.
    Old table contents Old table contents
    Unchanged contents Unchanged contents
    New table contents New table contents
    Unchanged contents Unchanged contents
  • Protocol summary

    The main objective of this study is evaluating bio-equivalency of two sustained release Triptorelin vials manufactured by Ronak Darou and IPSEN in patients with prostate cancer. As determining the blood level of this product is too complicated and could not be done by routine methods, measurement of biologic response to the medication, including serum Prostate Specific Antigen (PSA) and Testosterone levels, is recommended as surrogate of blood level to compare bio-equivalency of generic and brand forms of Triptorelin. In this double blinded, single center, randomized clinical trial, 100 patients diagnosed with high risk, stage 4 metastatic prostate cancer with Gleason score (GS)>8 and PSA >20, will be recruited. After signing the written consent form, patients randomly (using random number table) will be assigned to brand (Diphereline, IPSEN, France) and generic forms of sustained release Triptorelin acetate (Decareline, Ronak Darou, Iran), on a 1:1 basis, 3.75mg by IM injection every 28 days for 3 months. Before injection of each dose of medication, blood sample for measurement of PSA and Testosterone serum level, using Vidas kits manufactured by Biomerieux- France, will be collected from subjects.
    empty
    هدف از اين مطالعه بررسي همسنگي زيستي داروي تريپتورلين استات ساخته شده توسط شرکت روناک دارو با داروي ساخته شده توسط شرکت IPSEN در بیماران با کانسر پروستات میباشد. از آنجایی که تعيين غلظت دارو در مايعات بيولوژيک با روشهای معمول مقدور نمي باشد، ارزیابی پاسخ بيولوزيک به دارو شامل اندازه گیری سطح سرمي تستوسترون و آنتی آن اختصاصی پروستات (PSA) به عنوان معیار سطح خونی برای مقایسه هم ارزی زیستی فراورده های ژنریک و برند دارو توصیه میشود. در این مطالعه بالینی تک مرکزی، دو سویه کور و تصادفی شده، تعداد يک صد بيمار تازه شناخته شدة سرطان پروستات که در مرحلة high risk و stage 4 بیماری با Gleason score (GS)> 8 و PSA>20 بوده، و در معاينه باليني قابل عمل نيستند با رضايت نامه شخصي يا افراد درجه اول خانواده وارد مطالعه مي شوند. بيماران به طور تصادفي (با استفاده از جدول اعداد تصادفی) و با نسبت یک به یک داروي تريپتورلين آهسته رهش ساخت شرکت IPSEN فرانسه یا روناک داروی ایران، با دوز 3.75 میلی گرم به صورت تزریق عضلانی هر 28 روز یک بار و به مدت 3 ماه، را دریافت خواهند کرد. قبل از تزريق هر دوز دارو يک نمونه خونی از بیمار گرفته شده و سطح سرمي تستوسترون و PSA با استفاده از کیتهای Vidas ساخت شرکت Biomerieux فرانسه اندازه گیری خواهد شد.
    empty
    empty
    The main objective of this study is evaluating bio-equivalency of two sustained release Triptorelin vials manufactured by Ronak Darou and IPSEN in patients with prostate cancer. As determining the blood level of this product is too complicated and could not be done by routine methods, measurement of biologic response to the medication, including serum Prostate Specific Antigen (PSA) and Testosterone levels, is recommended as surrogate of blood level to compare bio-equivalency of generic and brand forms of Triptorelin
    empty
    هدف از اين مطالعه بررسي همسنگي زيستي داروي تريپتورلين استات ساخته شده توسط شرکت روناک دارو با داروي ساخته شده توسط شرکت IPSEN در بیماران با کانسر پروستات میباشد. از آنجایی که تعيين غلظت دارو در مايعات بيولوژيک با روشهای معمول مقدور نمي باشد، ارزیابی پاسخ بيولوزيک به دارو شامل اندازه گیری سطح سرمي تستوسترون و آنتی آن اختصاصی پروستات (PSA) به عنوان معیار سطح خونی برای مقایسه هم ارزی زیستی فراورده های ژنریک و برند دارو توصیه میشود
    empty
    Two arm parallel group randomised trial
    empty
    کارآزمایی بالینی تصادفی شده با دو گروه موازی
    empty
    This study will be done in urology clinic of Shahid Labbafinejhad hospital and patients and physicians will be blinded to study arms
    empty
    مطالعه در کلینیک اورولوژی بیمارستان شهید لبافی نژاد انجام شده و بیمار و پزشک معالجه گر نسبت به گروههای مطالعه هیچ آگاهی نخواهند داشت
    empty
    50 patients diagnosed with metastatic prostate cancer will be recruited after signing the written consent form
    empty
    تعداد پنجاه بيمار تازه شناخته شده سرطان پروستات با رضايت نامه شخصي يا افراد درجه اول خانواده وارد مطالعه خواهند شد.
    empty
    Patients randomly (using random number table) will be assigned to brand (Diphereline, IPSEN, France) and generic forms of sustained release Triptorelin acetate (Decareline, Ronak Darou, Iran), on a 1:1 basis, 3.75mg by IM injection every 28 days for 3 months.
    empty
    بيماران به طور تصادفي (با استفاده از جدول اعداد تصادفی) و با نسبت یک به یک داروي تريپتورلين آهسته رهش ساخت شرکت IPSEN فرانسه یا روناک داروی ایران، با دوز 3.75 میلی گرم به صورت تزریق عضلانی هر 28 روز یک بار و به مدت 3 ماه، را دریافت خواهند کرد.
    empty
    Prostate Specific Antigen (PSA) serum level Testostrone serum level
    empty
    سطح سرمی آنتی ژن اختصاصی پروستات سطح سرمی تستوسترون
  • General information

    1
    1
    1
    100
    50
    No
    Yes
    empty
    4
    2017-10-22, 1396/07/30
    2019-07-22, 1398/04/31
    Metastatic prostate cancer
    Signing written consent form
    بیمار مبتلا به کانسر متاستاتیک پروستات
    موافقت بیمار برای ورود به مطالعه با امضای رضایت نامه آگاهانه
    Hypothalamic pituitary gonadal axis dysfunction
    Malignancy other than prostate cancer
    Treatment with other Gonadotropin Releasing Hormone (GnRH) analogues, hormones, radiotherapy or chemotherapy during recent three months
    Allergy to GnRH, GnRH analogues or to any component of medications
    وجود اختلال در محور هیپوتالاموس-هیپوفیز-گنادها
    وجود همزمان بدخیمی فعال با منشا متفاوت
    دریافت قبلی آنالوگهای هورمون آزاد کننده گونادوتروپین (GnRH) و یا سایر درمان های هورمونی یا کموتراپی یا رادیو تراپی در سه ماه گذشته
    هرگونه سابقه حساسیت به GnRH، مشتقات GnRH یا اجزای فرمولاسیون
    Randomization will be done using simple randomization method by Rnd function of Excel software. In order to run the study in double blinded manner, the study medications will be packed and labeled by Ronak Darou in identical containers. Researchers and patients are not aware of the codes. At the end of the study all data will be analyzed by A and B codes and will be send to researcher who is responsible for scientific inquiries of the study. Then the medications will be decoded. Finally data will be send to Ronak Darou.
    برای تصادفی سازی مطالعه از جدول اعداد تصادفی ایجاد شده با استفاده از دستور Rnd نرم افزار Excel استفاده خواهد شد. برای دو سویه کور کردن مطالعه، داروها در بسته بندی کاملا یکسان توسط شرکت روناک دارو تهیه می شوند. روی هر کدام از داروها برچسب A یا B چسبانده می شود. کد داروها در اختیار شرکت روناک دارو بوده و محققان و بیماران از آن بی اطلاع هستند. پس از آنالیز نهایی و ارسال نتایج آنالیز بر اساس گروههای A و B به مسوول علمی مطالعه کدهای دارو به محققین اعلام خواهد شد. پس از مشخص شدن کدها نتایج به شرکت داروسازی روناک دارو ارسال خواهد شد.
    empty
    Randomization will be done using individualized simple randomization method by Rnd function of Excel software.
    empty
    تصادفی سازی مطالعه به صورت تصادفی سازی ساده فردی با استفاده از جدول اعداد تصادفی ایجاد شده با استفاده از دستور Rnd نرم افزار Excel استفاده خواهد شد
    empty
    Patients who are candidate to receive triptorelin, based on physician's decision, will be referred to researcher and using pre-designed randomization table will be allocated in study arms. Data will be send to data analyzer using codes and decoding will be done after completion of data analysis.
    empty
    در این مطالعه بیمارانی که بر اساس نظر پزشک معالج کاندیدای دریافت تریپتورلین هستند، به محقق معرفی می گردند. بر اساس جدول رندوم از پیش تعیین شده که نزد محقق می باشد، بیماران در یکی از گروههای درمانی قرار گرفته و تزریق دارو توسط پرستار انجام می شود. برای کور کردن متخصص آمار، اطلاعات جمع آوری شده از بیماران به صورت کد بندی شده به متخصص آمار داده شده و پس از اتمام آنالیز کدها باز خواهند شد.
    5 ml of venous blood
    ۵ میلی لیتر خون وریدی
  • Recruitment centers

    #1
    Name of recruitment center - English: Urology clinic, Shahid Labbafinejad hospital
    Name of recruitment center - Persian: کلینیک اورولوژی بیمارستان شهید لبافی نژاد
    Full name of responsible person - English: Shadi Ziaei
    Full name of responsible person - Persian: شادی ضیائی
    Street address - English: 9th Boostan St., Pasdaran
    Street address - Persian: پاسداران، خیابان بوستان نهم
    City - English: Tehran
    City - Persian: تهران
    Province:
    Country: Iran (Islamic Republic of)
    Postal code:
    Phone:
    Fax:
    Email:
    Web page address:
    Name of recruitment center - English: Urology clinic, Shahid Labbafinejad hospital
    Name of recruitment center - Persian: کلینیک اورولوژی بیمارستان شهید لبافی نژاد
    Full name of responsible person - English: Shadi Ziaei
    Full name of responsible person - Persian: شادی ضیائی
    Street address - English: 9th Boostan St., Pasdaran
    Street address - Persian: پاسداران، خیابان بوستان نهم
    City - English: Tehran
    City - Persian: تهران
    Province: Tehran
    Country: Iran (Islamic Republic of)
    Postal code: 1985717443
    Phone: +98 21 23601
    Fax:
    Email: shadi_z73@yahoo.com
    Web page address:
  • Sponsors / Funding sources

    #1
    contact.organization_id:
    Name of organization / entity - English: Vice chancellor for research, Shahid Beheshti University of Medical Sciences University of Medical S
    Name of organization / entity - Persian: دانشگاه علوم پزشکی شهید بهشتی
    Full name of responsible person - English: Tahereh Shams
    Full name of responsible person - Persian: طاهره شمس
    Street address - English: Velenjak Street, Shahid Chamran High Way
    Street address - Persian: بزرگراه چمران، خیابان ولنجک
    City - English: Tehran
    City - Persian: تهران
    Province:
    Country: Iran (Islamic Republic of)
    Postal code:
    Phone:
    Fax:
    Email:
    Web page address:

    Name of organization / entity - English:
    Name of organization / entity - Persian:
    Full name of responsible person - English: Tahereh Shams
    Full name of responsible person - Persian: طاهره شمس
    Street address - English: Velenjak Street, Shahid Chamran High Way
    Street address - Persian: بزرگراه چمران، خیابان ولنجک
    City - English: Tehran
    City - Persian: تهران
    Province: Tehran
    Country: Iran (Islamic Republic of)
    Postal code: 1985717443
    Phone: +98 21 8820 0102
    Fax:
    Email: T_shams@yahoo.com
    Web page address:
    100
    50
    empty
    Public
    empty
    Domestic
    empty
    Academic
    Vice chancellor for research, Shahid Beheshti University of Medical Sciences University of Medical S
    Shahid Beheshti University of Medical Sciences
    دانشگاه علوم پزشکی شهید بهشتی
    دانشگاه علوم پزشکی شهید بهشتی
    #2
    contact.organization_id:
    Name of organization / entity - English: Ronak Pharm
    Name of organization / entity - Persian: روناک دارو
    Full name of responsible person - English: Zahra kourorian
    Full name of responsible person - Persian: زهرا کروریان
    Street address - English: 3rd Floor, No.85, Gomnam St., Fatemi Sq., Tehran.
    Street address - Persian: تهران، میدان فاطمی، خیابان شهید گمنام، نرسیده به میدان گلها، نبش خیابان شماره 2/1، پلاک شماره 85، طبقه سوم
    City - English: Tehran
    City - Persian: تهران
    Province: Tehran
    Country: Iran (Islamic Republic of)
    Postal code: 1431614481
    Phone: +98 21 8839 0564
    Fax:
    Email: zkourorian@gmail.com
    Web page address:
    empty
    Yes
    empty
    50
    empty
    Private
    empty
    Domestic
    empty
    Industry
    empty
    Ronak Pharm
    empty
    روناک دارو
  • Person responsible for general inquiries

    contact.organization_id:
    Name of organization / entity - English: Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences
    Name of organization / entity - Persian: دانشگاه علوم پزشکی شهید بهشتی، دانشکده داروسازی
    Full name of responsible person - English: Mohammad Sistanizad
    Full name of responsible person - Persian: محمد سیستانی زاد
    Position - English: Assistant Professor / Clinical Pharmacy Specialist
    Position - Persian: متخصص داروسازی بالینی/ استادیار
    Latest degree:
    Area of specialty/work: 0
    Area of specialty/work title - English:
    Area of specialty/work title - Persian:
    Street address - English: Department of Clinical Pharmacy, Faculty of Pharmacy, Niayesh Highway
    Street address - Persian: بزرگراه نیایش، داشکده داروسازی، گروه داروسازی بالینی
    City - English: Tehran
    City - Persian: تهران
    Province:
    Province - English:
    Province - Persian:
    contact.provinces_available: 1
    Country: Iran (Islamic Republic of)
    Postal code:
    Phone: +98 218800087
    Mobile: +98 912 278 4895
    Fax:
    Email: sistanizadm@sbmu.ac.ir
    Web page address:

    Name of organization / entity - English:
    Name of organization / entity - Persian:
    Full name of responsible person - English: Mohammad Sistanizad
    Full name of responsible person - Persian: محمد سیستانی زاد
    Position - English: Associate Professor / Clinical Pharmacy Specialist
    Position - Persian: متخصص داروسازی بالینی/ دانشیار
    Latest degree: phd
    Area of specialty/work: 41
    Area of specialty/work title - English:
    Area of specialty/work title - Persian:
    Street address - English: Department of Clinical Pharmacy, Faculty of Pharmacy, Niayesh Highway
    Street address - Persian: بزرگراه نیایش، داشکده داروسازی، گروه داروسازی بالینی
    City - English: Tehran
    City - Persian: تهران
    Province: Tehran
    Province - English:
    Province - Persian:
    contact.provinces_available: 1
    Country: Iran (Islamic Republic of)
    Postal code: 1991953381
    Phone: +98 218800087
    Mobile: +98 912 278 4895
    Fax:
    Email: sistanizadm@sbmu.ac.ir
    Web page address:
  • Person responsible for scientific inquiries

    contact.organization_id:
    Name of organization / entity - English: Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences
    Name of organization / entity - Persian: دانشگاه علوم پزشکی شهید بهشتی، دانشکده داروسازی
    Full name of responsible person - English: Mohammad Sistanizad
    Full name of responsible person - Persian: محمد سیستانی زاد
    Position - English: Assistant Professor / Clinical Pharmacy Specialist
    Position - Persian: متخصص داروسازی بالینی/ استادیار
    Latest degree:
    Area of specialty/work: 0
    Area of specialty/work title - English:
    Area of specialty/work title - Persian:
    Street address - English: Department of Clinical Pharmacy, Faculty of Pharmacy, Niayesh Highway
    Street address - Persian: بزرگراه نیایش، داشکده داروسازی، گروه داروسازی بالینی
    City - English: Tehran
    City - Persian: تهران
    Province:
    Province - English:
    Province - Persian:
    contact.provinces_available: 1
    Country: Iran (Islamic Republic of)
    Postal code:
    Phone: +98 218800087
    Mobile: +98 912 278 4895
    Fax:
    Email: sistanizadm@sbmu.ac.ir
    Web page address:

    Name of organization / entity - English:
    Name of organization / entity - Persian:
    Full name of responsible person - English: Mohammad Sistanizad
    Full name of responsible person - Persian: محمد سیستانی زاد
    Position - English: Associate Professor / Clinical Pharmacy Specialist
    Position - Persian: متخصص داروسازی بالینی/دانشیار
    Latest degree: phd
    Area of specialty/work: 41
    Area of specialty/work title - English:
    Area of specialty/work title - Persian:
    Street address - English: Department of Clinical Pharmacy, Faculty of Pharmacy, Niayesh Highway
    Street address - Persian: بزرگراه نیایش، داشکده داروسازی، گروه داروسازی بالینی
    City - English: Tehran
    City - Persian: تهران
    Province: Tehran
    Province - English:
    Province - Persian:
    contact.provinces_available: 1
    Country: Iran (Islamic Republic of)
    Postal code: 1991953381
    Phone: +98 218800087
    Mobile: +98 912 278 4895
    Fax:
    Email: sistanizadm@sbmu.ac.ir
    Web page address:
  • Person responsible for updating data

    contact.organization_id:
    Name of organization / entity - English: Department of Clinical Pharmacy, Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences
    Name of organization / entity - Persian: دانشگاه علوم پزشکی شهید بهشتی، دانشکده داروسازی
    Full name of responsible person - English: Mohammad Sistanizad
    Full name of responsible person - Persian: محمد سیستانی زاد
    Position - English: Assistant Professor / Clinical Pharmacy Specialist
    Position - Persian: متخصص داروسازی بالینی/ استادیار
    Latest degree:
    Area of specialty/work: 0
    Area of specialty/work title - English:
    Area of specialty/work title - Persian:
    Street address - English: Department of Clinical Pharmacy, Faculty of Pharmacy, Niayesh Highway
    Street address - Persian: بزرگراه نیایش، داشکده داروسازی، گروه داروسازی بالینی
    City - English: Tehran
    City - Persian: تهران
    Province:
    Province - English:
    Province - Persian:
    contact.provinces_available: 1
    Country: Iran (Islamic Republic of)
    Postal code:
    Phone: +98 218800087
    Mobile: +98 912 278 4895
    Fax:
    Email: sistanizadm@sbmu.ac.ir
    Web page address:

    Name of organization / entity - English:
    Name of organization / entity - Persian:
    Full name of responsible person - English: Mohammad Sistanizad
    Full name of responsible person - Persian: محمد سیستانی زاد
    Position - English: AssociateProfessor / Clinical Pharmacy Specialist
    Position - Persian: متخصص داروسازی بالینی/ دانشیار
    Latest degree: phd
    Area of specialty/work: 41
    Area of specialty/work title - English:
    Area of specialty/work title - Persian:
    Street address - English: Department of Clinical Pharmacy, Faculty of Pharmacy, Niayesh Highway
    Street address - Persian: بزرگراه نیایش، داشکده داروسازی، گروه داروسازی بالینی
    City - English: Tehran
    City - Persian: تهران
    Province: Tehran
    Province - English:
    Province - Persian:
    contact.provinces_available: 1
    Country: Iran (Islamic Republic of)
    Postal code: 1991953381
    Phone: +98 218800087
    Mobile: +98 912 278 4895
    Fax:
    Email: sistanizadm@sbmu.ac.ir
    Web page address:
  • Sharing plan

    yes
    yes
    no
    yes
    yes
    no
    no
    empty
    Data related to primary objectives
    empty
    داده های مربوط به پیامدهای اصلی
    empty
    Starting 6 months after publication
    empty
    شروع دوره دسترسی 6 ماه پس از چاپ نتایج
    empty
    People working in academic institutions; pharmaceutical companies
    empty
    محققین دانشگاهی‌; شرکتهای دارویی
    empty
    With official letter
    empty
    با درخواست کتبی
    empty
    Mohammad Sistanizad
    empty
    محمد سیستانی زاد
    empty
    Data are available 6 months after publication of results
    empty
    بعد از چاپ نتایج بلامانع هست

Protocol summary

Study aim
The main objective of this study is evaluating bio-equivalency of two sustained release Triptorelin vials manufactured by Ronak Darou and IPSEN in patients with prostate cancer. As determining the blood level of this product is too complicated and could not be done by routine methods, measurement of biologic response to the medication, including serum Prostate Specific Antigen (PSA) and Testosterone levels, is recommended as surrogate of blood level to compare bio-equivalency of generic and brand forms of Triptorelin
Design
Two arm parallel group randomised trial
Settings and conduct
This study will be done in urology clinic of Shahid Labbafinejhad hospital and patients and physicians will be blinded to study arms
Participants/Inclusion and exclusion criteria
50 patients diagnosed with metastatic prostate cancer will be recruited after signing the written consent form
Intervention groups
Patients randomly (using random number table) will be assigned to brand (Diphereline, IPSEN, France) and generic forms of sustained release Triptorelin acetate (Decareline, Ronak Darou, Iran), on a 1:1 basis, 3.75mg by IM injection every 28 days for 3 months.
Main outcome variables
Prostate Specific Antigen (PSA) serum level Testostrone serum level

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT2016090410178N10
Registration date: 2016-10-29, 1395/08/08
Registration timing: registered_while_recruiting

Last update: 2018-07-28, 1397/05/06
Update count: 1
Registration date
2016-10-29, 1395/08/08
Registrant information
Name
Mohammad Sistanizad
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 8820 0087
Email address
sistanizadm@sbmu.ac.ir
Recruitment status
Recruitment complete
Funding source
Ronak Pharm
Expected recruitment start date
2016-10-22, 1395/08/01
Expected recruitment end date
2019-07-22, 1398/04/31
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparative bioequivalence study of two sustained release Triptorelin vials manufactured by Ronak Darou and IPSEN in patients with prostate cancer based on biologic response (serum PSA and Testosterone levels)
Public title
Bioequivalence study of two Triptorelin vials manufactured by Ronak Darou and IPSEN in patients with prostate cancer
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Metastatic prostate cancer Signing written consent form
Exclusion criteria:
Hypothalamic pituitary gonadal axis dysfunction Malignancy other than prostate cancer Treatment with other Gonadotropin Releasing Hormone (GnRH) analogues, hormones, radiotherapy or chemotherapy during recent three months Allergy to GnRH, GnRH analogues or to any component of medications
Age
From 18 years old
Gender
Male
Phase
2-3
Groups that have been masked
  • Participant
  • Care provider
  • Data analyser
Sample size
Target sample size: 50
More than 1 sample in each individual
Number of samples in each individual: 4
5 ml of venous blood
Randomization (investigator's opinion)
Randomized
Randomization description
Randomization will be done using individualized simple randomization method by Rnd function of Excel software.
Blinding (investigator's opinion)
Double blinded
Blinding description
Patients who are candidate to receive triptorelin, based on physician's decision, will be referred to researcher and using pre-designed randomization table will be allocated in study arms. Data will be send to data analyzer using codes and decoding will be done after completion of data analysis.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Shahid Beheshti University of Medical Sciences
Street address
Velenjak Street, Shahid Chamran High Way
City
Tehran
Province
Tehran
Postal code
1985717443
Approval date
2016-07-20, 1395/04/30
Ethics committee reference number
IR.SBMU.PHNM.1395.408

Health conditions studied

1

Description of health condition studied
Metastatic prostate cancer
ICD-10 code
C61
ICD-10 code description
Malignant neoplasm of prostate

Primary outcomes

1

Description
Prostate Specific Antigen (PSA) serum level
Timepoint
Before injection of each dose of medication for 3 months
Method of measurement
Biomerieux Vidas kits

2

Description
Testostrone serum level
Timepoint
Before injection of each dose of medication for 3 months
Method of measurement
Biomerieux Vidas kits

Secondary outcomes

empty

Intervention groups

1

Description
Diphereline (Triptorelin acetate manufactured by IPSEN, France) 3.75mg IM every 28 days for 3 doses
Category
Treatment - Drugs

2

Description
Decareline (Triptorelin acetate manufactured by Ronak Darou, Iran) 3.75mg IM every 28 days for 3 doses
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Urology clinic, Shahid Labbafinejad hospital
Full name of responsible person
Shadi Ziaei
Street address
9th Boostan St., Pasdaran
City
Tehran
Province
Tehran
Postal code
1985717443
Phone
+98 21 23601
Email
shadi_z73@yahoo.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Tahereh Shams
Street address
Velenjak Street, Shahid Chamran High Way
City
Tehran
Province
Tehran
Postal code
1985717443
Phone
+98 21 8820 0102
Email
T_shams@yahoo.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Shahid Beheshti University of Medical Sciences
Proportion provided by this source
50
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

2

Sponsor
Name of organization / entity
Ronak Pharm
Full name of responsible person
Zahra kourorian
Street address
3rd Floor, No.85, Gomnam St., Fatemi Sq., Tehran.
City
Tehran
Province
Tehran
Postal code
1431614481
Phone
+98 21 8839 0564
Email
zkourorian@gmail.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Ronak Pharm
Proportion provided by this source
50
Public or private sector
Private
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Industry

Person responsible for general inquiries

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Mohammad Sistanizad
Position
Associate Professor / Clinical Pharmacy Specialist
Latest degree
Ph.D.
Other areas of specialty/work
Medical Pharmacy
Street address
Department of Clinical Pharmacy, Faculty of Pharmacy, Niayesh Highway
City
Tehran
Province
Tehran
Postal code
1991953381
Phone
+98 218800087
Fax
Email
sistanizadm@sbmu.ac.ir
Web page address

Person responsible for scientific inquiries

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Mohammad Sistanizad
Position
Associate Professor / Clinical Pharmacy Specialist
Latest degree
Ph.D.
Other areas of specialty/work
Medical Pharmacy
Street address
Department of Clinical Pharmacy, Faculty of Pharmacy, Niayesh Highway
City
Tehran
Province
Tehran
Postal code
1991953381
Phone
+98 218800087
Fax
Email
sistanizadm@sbmu.ac.ir
Web page address

Person responsible for updating data

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Mohammad Sistanizad
Position
AssociateProfessor / Clinical Pharmacy Specialist
Latest degree
Ph.D.
Other areas of specialty/work
Medical Pharmacy
Street address
Department of Clinical Pharmacy, Faculty of Pharmacy, Niayesh Highway
City
Tehran
Province
Tehran
Postal code
1991953381
Phone
+98 218800087
Fax
Email
sistanizadm@sbmu.ac.ir
Web page address

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
No - There is not a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
No - There is not a plan to make this available
Data Dictionary
No - There is not a plan to make this available
Title and more details about the data/document
Data related to primary objectives
When the data will become available and for how long
Starting 6 months after publication
To whom data/document is available
People working in academic institutions; pharmaceutical companies
Under which criteria data/document could be used
With official letter
From where data/document is obtainable
Mohammad Sistanizad
What processes are involved for a request to access data/document
Data are available 6 months after publication of results
Comments
Loading...